(NASDAQ:MTVA) announced positive results from the Phase 1 Part 2 multiple ascending dose (MAD) trial of DA-1726 in obesity.

Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

SEATTLE, WA / ACCESS Newswire / April 22, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...

The 2018 and 2020 sell-offs were very short-lived, but it took until early 2024 for the Nasdaq to reach a new high after the ...

(RTTNews) - Lipocine Inc. (LPCN), a biopharmaceutical company specializing in oral drug delivery, has commenced a Phase ... at $3.6359 or 2.13% higher on the Nasdaq Capital Market.

following the footsteps of the Nasdaq 100, which closed in bear territory on Friday. The three-day decline has grown to as much as 14%. These charts show just how painful the market implosion has ...

One of those is Broadcom (NASDAQ: AVGO), as the market hasn't priced in the future growth of an exciting product line. At one ...

Bitcoin bides its time above $80,000 as stocks fail to rally on low inflation and three-year US Dollar Index lows.

Price action: The daily chart shows the two previously available entry points on a ‘breakdown trade’ as ‘1’ and ‘2’. At this stage, there is no new such setup. In such a fast moving market, a break ...

Let's check out three of my favorite AI stocks to buy before they soar. Palantir Technologies (NASDAQ ... forecasts for the AI market. On top of this, we're in the early stages of the AI story ...

2025 has proven to feel so difficult because when markets and or the economy are hit with supply or demand shocks, ...